Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)

NCT06996652 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT06996652
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06996652 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)
Lead sponsor
Yale University
Phase
Phase 2
Overall status
Recruiting
Start date
August 17, 2026
Completion date
January 1, 2030
Enrollment
108 (estimated)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

rem sleep behavior disorder